The programme aims to provide critical healthcare services to approximately 4 lakh people in remote and resource-scarce communities
The new single-use commercial facility will be among India’s largest, featuring advanced technologies to produce high-quality biologics and specialty pharmaceuticals
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
The Phase Ib MAD study is a randomized, double-blind, placebo-controlled trial conducted in the United States
Shantived Hospital generated revenue of around Rs 50 crore in FY2025
The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
Attorney General Ken Paxton sued pharmaceutical giant Eli Lilly for bribing and illegally inducing medical providers to prescribe its most profitable drugs
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
This aims to benefit approximately 4.5 crore families with six crore senior citizens with Rs. 5 lakh free health insurance cover on a family basis
Subscribe To Our Newsletter & Stay Updated
